<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Neuro Therapies

What’s New in Neuromodulation for Spring 2022

In the market for neuromodulation, companies are developing spinal cord stimulation (SCS), deep brain st...

Neuro Therapies

The State of Cybersecurity in Healthcare

Jason Winkler, Sales VP of cybersecurity startup Device Authority, discusses the state of cybersecurity ...

Neuro Therapies

Wallaby Acquires phenox GmBH

Wallaby Medical announced it has acquired phenox GmbH, including phenox's femtos GmbH, a German-based ne...

Neuro Therapies

Abbott: Expanding the Ecosystem in DBS - An Interview with Binith Cheeran

Abbott’s Binith Cheeran, MD, PhD discusses the latest trends in DBS as well as the Company’s strategies ...

Neuro Therapies

A New View: AI-Driven Imaging

In this article, SmartTRAK reviews the development of AI in healthcare and profiles four companies imple...

Neuro Therapies

NANS 2022: What's New for Abbott Neuromodulation

Abbott’s Allen Burton, MD discusses the Company’s new MRI labeling, expanded payer coverage for DRG, big...

Neuro Therapies

Medtronic: The Future of Neuromodulation in 2022 and Beyond

Medtronic Neuromodulation executives Dave Anderson and Charlie Covert discuss the Company and the future...

Neuro Therapies

An Interview with Nevro's D. Keith Grossman

D. Keith Grossman, chairman, CEO and president of Nevro Corporation, discusses the Company, expanding in...

Neuro Therapies

Meet Shelly Caruso - Market Analyst/Medical Writer

We are pleased to announce that Shelly Caruso has joined the team at SmartTRAK as a Market Analyst/Medic...

Neuro Therapies

SCS Boomerangs Back: Q221 Market Report

A big boost in Q2 with double-digit gains in all segments. The US and WW SCS Market boomeranged to pre-C...

1
...
5 6 7
...
14